$948.45
-26.51 (-2.72%)
As of May 8, 9:30 PM ET ·
Analyst Consensus
Strong Buy
39
Analysts
Very High
Coverage
Buy 30 77%
Hold 8 21%
Sell 1 3%
Price Target
Analyst Price Target +40.3% upside
Low Target $960.24
Average Target $1,330.33
High Target $1,470.76
Current Price $948.45
Current
$948.45
Target
$1,330.33
$960.24 $1,330.33 avg $1,470.76
Scenario Analysis
Bear Case
$960.24
1.2%
Low target
Base Case
$1,330.33
+40.3%
Avg target
Bull Case
$1,470.76
+55.1%
High target
Risk/Reward
44.3x
Highly favorable
Price in Context
52-Week High
$1,133.95
-16.4% from high
52-Week Low
$623.78
+52.0% from low
50-Day SMA
$1,050.28
-9.7% vs SMA
200-Day SMA
$866.44
+9.5% vs SMA
RSI (14)
49.9
Neutral
Target vs 52W High
$1,330.33
+17.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%